On March 30, 2010, President Obama signed into law the Health Care and Education Reconciliation Act of 2010, enacting a 2.3% excise tax on any medical device identified in Section 201(h) of the Federal Food, Drug & Cosmetic Act, including many that may not be at first glance thought of as a medical device. More that a year later most companies are still struggling or have yet to deal with uncertainties that still exist, including how and when the tax is determined and whether they will bear the burden of the tax. At this complimentary seminar, Ernst and Young’s Chris Ohmes and other national leaders on the topic will share insights and industry experience, as well as explain how Indiana companies may be able to plan for determining the correct tax to pay and how to minimize potential for overpayment. The mandatory tax takes effect January 1, 2013, but now is the time for Indiana companies to begin planning to comply with the tax and to reduce its impact on their bottom line.
Monday, October 3, 2011
Ernst & Young LLP
111 Monument Circle | 3rd Floor Tower Side, Conference Room C
Indianapolis, Indiana 46204
9:00 a.m. – 11:00 a.m.
Registration opens at 8:30 a.m. Continental breakfast will be provided.
Who should attend:
This course is appropriate for CFO, Controllers, Tax Directors, VPs of Finance.
Please RSVP to Kathy Jacobson at firstname.lastname@example.org or call +1 317 681 7701 by Tuesday, September 27, 2011 to reserve your spot at this event. When RSVPing, please note if you’re also interested in a private meeting with members of Ernst & Young’s National Tax team on October 3rd from 11 a.m. – 12 p.m.
Space is limited and registration will close once capacity is reached.This course is complimentary. There is no registration fee. Continuing professional education (CPE) credits will be awarded.
For additional information, please contact Kathy Jacobson at email@example.com or call +1 317 681 7701.